News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th, 2026.
The consensus price target hints at a 27.8% upside potential for Amphenol (APH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Amphenol's AI-driven IT datacom growth, record orders and stronger earnings momentum give it an edge over nVent Electric.
ANF, APH and CBRL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 16th, 2026.
ANF, APH, PARR, HPQ and SBLK have been added to the Zacks Rank #1 (Strong Buy) List on September 16th, 2026.
TTMI sees N+M scaling into a $600 million business in the second half as AI data-center demand and improving yields support growth.
Amphenol's premium valuation is backed by surging AI demand, diversified end markets, strong cash flow and improving acquisition contributions.
Amphenol (APH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Outpacing the Dow over the past 12 months, Amphenol continues to receive a highly bullish outlook from Wall Street analysts, reflecting confidence in the company’s long-term prospects.
Palo Alto Networks' Q4 earnings beat estimates as revenues rise 34%, fueled by broad platform growth, record adoption and a 63% jump in NGS ARR.
Amphenol's Communications Solutions growth is surging as AI datacom demand and acquisitions fuel gains, even as TE Connectivity and Bel Fuse intensify competition.
Marvell Technology's AI-driven connectivity growth outpaces Amphenol, but its premium valuation makes APH the safer bet for now.
The consensus price target hints at a 25.7% upside potential for Amphenol (APH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.
APH's AI-driven demand, diversified markets, strong orders and acquisition gains support growth, though shares trade at a premium valuation.
Quantum Computing's Q2 loss matches estimates as revenues surge on photonics sales, but higher costs and gross loss pressure profitability.
Dividend-growth stocks like Dell Technologies, Taiwan Semiconductor and three others offer income, growth and resilience as rate hike concerns ease.
Yahoo Finance Markets and Data Editor Jared Blikre examines the comeback seen across the semiconductor landscape over the past five trading days, while also analyzing which companies are emerging as leaders in the renewed AI rally.
Amphenol (APH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Amphenol (APH) have what it takes to be a top stock pick for momentum investors? Let's find out.
ENTG beats Q2 estimates as AI-linked chip investment lifts sales, margins and cash flow, while stronger bookings improve visibility into 2027.
QLYS tops Q2'26 estimates as channel revenues jump 22%, margins widen, and management raises its 2026 revenue and earnings outlook.
Ichor's Q2 earnings beat estimates as margin gains offset a revenue miss, while strong demand fuels upbeat 2026 growth and Q3 guidance.
Cohu's Q2 earnings and revenues beat estimates as AI compute demand, higher tester and recurring sales and a favorable mix lift results.
CHKP tops Q2 earnings estimates as subscription revenues rise and AI security demand expands, even as product sales and cash flow face pressure.
UMC beats Q2 estimates as revenues rise 8.4%, margins expand and record 22-nanometer sales strengthen results.
Amphenol (APH) is well positioned to outperform the market, as it exhibits above-average growth in financials.